Company information
Healthcare-Focused Private Equity & Venture Capital
REDMILE PRIVATE INVESTMENTS I (GP), LLC partners with visionary healthcare companies to accelerate growth and innovation. As a specialized hedge fund and asset manager, we invest $5–$50 million in promising firms across biotechnology, pharmaceuticals, medical devices, and digital health. Our focus is on catalyzing transformative change through both private equity and venture capital strategies tailored to the evolving healthcare sector.
01 / What we do
We collaborate with innovative companies across the healthcare spectrum. Our capital and expertise support breakthrough solutions, organizational scaling, and long-term value creation in key verticals:
We invest in pioneering firms developing breakthrough therapies, novel molecular entities, and advanced pharmaceutical platforms. Our funding enables the discovery, clinical development, and commercialization of science-driven innovations that have the potential to address unmet medical needs. Companies benefit from our sector expertise, rigorous due diligence, and strong industry networks that help facilitate regulatory and market success.
Discuss your idea ↗
Transformative technologies in the medical device sector are a core focus. We support companies designing next-generation diagnostic tools, implantable devices, and minimally invasive solutions. Our investment process prioritizes scalability, regulatory pathway clarity, and unmet clinical demand. We partner with management teams to accelerate time-to-market while emphasizing product safety and patient outcomes.
Discuss your idea ↗
Digital transformation is reshaping healthcare delivery. We back ventures leveraging technology to enhance patient care, streamline systems, and improve clinical outcomes—ranging from telemedicine and data analytics to AI-driven platforms. Our investments facilitate integration with healthcare infrastructure and drive adoption across providers, payers, and patients alike.
Discuss your idea ↗We identify and support service organizations offering innovative solutions to healthcare stakeholders. These include specialty healthcare providers, contract research organizations, and firms focused on value-based care models. Our funding empowers operational expansion, service diversification, and adoption of advanced technology to better serve patients and healthcare systems.
Discuss your idea ↗
02 / About us
REDMILE PRIVATE INVESTMENTS I (GP), LLC is dedicated to advancing the future of healthcare through strategic private capital. Operating from San Francisco, we combine deep industry expertise and flexible investment structures to meet the evolving needs of high-potential companies.
Our team engages closely with entrepreneurs, scientists, and executives, providing not only financial resources but also guidance rooted in sector knowledge and a global network of partners. We strive to catalyze innovation that improves patient outcomes and reshapes markets.
Our approach centers on collaborative value creation. From early-stage ventures in discovery and R&D through growth-stage companies scaling commercial operations, we tailor our support to individual business trajectories within the medical and health technology landscape.
Start a conversation ↗Our perspective
REDMILE PRIVATE INVESTMENTS I (GP), LLC uniquely combines the agility of venture capital with the rigor of private equity. Our understanding of scientific, regulatory, and commercial levers allows us to identify value across stages and support companies facing complex healthcare challenges. We prioritize meaningful relationships with portfolio firms, working towards shared milestones and sustainable advancement within the evolving global healthcare environment.
03 / How to get started
Submit a concise overview of your healthcare company, including sector, stage, and funding needs. Our team will review your fit with our investment focus and determine whether to initiate further due diligence, guided by strategic alignment.
If your company aligns with our mandate, we will request additional information including pitch materials, clinical or technological data, and relevant projections. This stage involves meetings with your leadership, clarifying growth plans and milestones.
We discuss potential investment mechanics, deal terms, and areas of value-add partnership. Because each transaction and company is unique, we clarify expectations on both sides before proceeding toward more detailed due diligence or investment documentation.
Practical guidance / 01
Our partnerships span a diverse range of company profiles within the healthcare industry. We are most effective with firms at key inflection points, whether preparing for clinical trials, regulatory clearance, or scaling commercial operations. Our approach values collaboration and clear communication.
Practical guidance / 02
To maximize your engagement, we recommend assembling detailed reports and forecasts. Clear articulation of your technology, product roadmap, regulatory plans, and commercial differentiation will significantly enhance the evaluation process and help us understand your vision.
Practical guidance / 03
Our investment mandate focuses strictly on healthcare and life sciences industries. We do not currently invest outside of this domain or in startups lacking validated concepts or scalability. Early alignment on scope improves the speed and clarity of our evaluation.
04 / A little more detail
We focus on companies operating in biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health. Preference is given to businesses demonstrating innovative science, differentiated technology, and clear potential for scaling within global healthcare markets.
We invest between $5 million and $50 million, supporting companies from early-stage clinical development through commercial expansion. Our flexibility allows us to consider both venture capital deployments and larger private equity transactions based on company maturity and need.
Our team brings sector expertise, operational guidance, and access to an extensive industry network. We work collaboratively with management on strategy, regulatory navigation, and growth planning—helping address practical challenges to unlock business milestones.
Prepare a concise introduction highlighting your core technology or service, target market, team, and funding requirements. Submitting investor presentations or executive summaries will help us quickly assess fit and coordinate a follow-up conversation if aligned.
We are interested in a broad spectrum of diseases, modalities, and digital health applications. While there may be portfolio preferences at a given time, we welcome innovative proposals from all areas within our healthcare investment scope.
05 / Contact us
If you have an innovative healthcare solution or growth-stage business and are seeking strategic investment, we encourage you to reach out. For inquiries regarding our investment criteria or process, please use the contact information provided. Our team will respond to relevant submissions and explore how we can support healthcare’s next generation of leaders.
Email us ↗